Abstract
Protein-protein interactions play key roles in all biological processes, motivating numerous campaigns to seek small-molecule disruptors of therapeutically relevant interactions. Two decades ago, the prospect of developing small-molecule inhibitors was thought to be perhaps impossible due to the potentially undruggable nature of the protein surfaces involved; this viewpoint was reinforced by the limited successes provided from traditional high-throughput screens. To date, however, refinement of new experimental approaches has led to a multitude of inhibitors against many different targets. Having thus established the feasibility of attaining success in this valuable and diverse target space, attention now turns to incorporating computational techniques that might assist during various stages of drug design and optimization. Here we review cases in which computational approaches – virtual screening, docking, and ligand optimization – have contributed to discovery of new inhibitors of protein-protein interactions. We conclude by providing an outlook into the upcoming challenges and recent advances likely to shape this field moving forward.
Keywords: Virtual screening, Ligand docking, Protein-protein interaction, Drug design, Protein pocket, HTS.
Current Topics in Medicinal Chemistry
Title:Computational Screening and Design for Compounds that Disrupt Protein-protein Interactions
Volume: 17 Issue: 23
Author(s): David K. Johnson and John Karanicolas*
Affiliation:
- Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111-2497,United States
Keywords: Virtual screening, Ligand docking, Protein-protein interaction, Drug design, Protein pocket, HTS.
Abstract: Protein-protein interactions play key roles in all biological processes, motivating numerous campaigns to seek small-molecule disruptors of therapeutically relevant interactions. Two decades ago, the prospect of developing small-molecule inhibitors was thought to be perhaps impossible due to the potentially undruggable nature of the protein surfaces involved; this viewpoint was reinforced by the limited successes provided from traditional high-throughput screens. To date, however, refinement of new experimental approaches has led to a multitude of inhibitors against many different targets. Having thus established the feasibility of attaining success in this valuable and diverse target space, attention now turns to incorporating computational techniques that might assist during various stages of drug design and optimization. Here we review cases in which computational approaches – virtual screening, docking, and ligand optimization – have contributed to discovery of new inhibitors of protein-protein interactions. We conclude by providing an outlook into the upcoming challenges and recent advances likely to shape this field moving forward.
Export Options
About this article
Cite this article as:
Johnson K. David and Karanicolas John *, Computational Screening and Design for Compounds that Disrupt Protein-protein Interactions, Current Topics in Medicinal Chemistry 2017; 17 (23) . https://dx.doi.org/10.2174/1568026617666170508153904
DOI https://dx.doi.org/10.2174/1568026617666170508153904 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 13
Current Medicinal Chemistry Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Role of Cations in the Interaction of Pradimicins with HIV-1 Envelope gp120
Current Topics in Medicinal Chemistry Bioinformatic Screening of Compounds from Iranian Lamiaceae Family Members against SARS-CoV-2 Spike Protein
Letters in Drug Design & Discovery Antimitotic Chalcones and Related Compounds as Inhibitors of Tubulin Assembly
Anti-Cancer Agents in Medicinal Chemistry Subject Index To Volume 12
Current Pharmaceutical Design Subject Index to Volume 3
Current Medicinal Chemistry - Anti-Cancer Agents Study of the Relationships between COVID-19, Associated Diseases, and Vitamins
Coronaviruses Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Current Cancer Drug Targets Editorial from Guest Editor [Hot topic: The Optimal Care of the Lung in the Critically Ill (Guest Editor: Ross Freebairn)]
Current Respiratory Medicine Reviews Cross-Talk between Oxidative Stress and Pro-Inflammatory Cytokines in Acute Pancreatitis: A Key Role for Protein Phosphatases
Current Pharmaceutical Design Viral Inactivation Based on Inhibition of Membrane Fusion: Understanding the Role of Histidine Protonation to Develop New Viral Vaccines
Protein & Peptide Letters Mitochondrial Functionality and Chemical Compound Action on Sperm Function
Current Medicinal Chemistry Mitochondrial Thymidine Kinase Inhibitors
Current Topics in Medicinal Chemistry Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Hypoxia in Pre-Eclampsia: Cause or Effect?
Current Women`s Health Reviews Development and Application of Fluorescence Polarization Assays in Drug Discovery
Combinatorial Chemistry & High Throughput Screening The Hidden Impact of COVID-19 on Sexual and Reproductive Health and Rights of Women in India
Current Women`s Health Reviews Diterpenoids from Liverworts and their Biological Activities
Current Organic Chemistry A2A Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry